iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
4 hedge funds and large institutions have $6.68M invested in iShares Genomics Immunology and Healthcare ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$5.44M |
| 2 |
Jane Street
New York
|
$880K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$2K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $5.44M | +$5.44M | +200,000 | New |
|
|
2
Jane Street
New York
| $880K | +$880K | +32,391 | New |
|
3
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $359K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | +$2K | +90 | New |
|